Mark Brister serves as Executive at DEXCOM INC, where they oversee executive responsibilities. Since joining the company, Mark Brister has executed 7 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 6, 2019 involved purchasing 5,000 shares valued at $20.0K.
Mark Brister currently holds 38,865 shares of DEXCOM INC (DXCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Brister has been a net seller of DXCM stock. They have purchased $20.0K and sold $1.2M worth of shares.
Mark Brister's most recent insider trade was on Aug 6, 2019, when they purchased 5,000 shares at $4.00 per share.
Get notified when new Form 4 filings are submitted
| $1.82 |
| Discretionary |
| Apr 30, 2018 | OBLN | $8.6K | Award | 2,622 | $3.27 | Discretionary |
| Jan 2, 2018 | OBLN | $0 | Award | 65,000 | $N/A | Discretionary |
| Oct 31, 2017 | OBLN | $13.3K | Award | 1,860 | $7.17 | Discretionary |
| Apr 30, 2017 | OBLN | $14.0K | Award | 1,550 | $9.03 | Discretionary |
| May 2, 2006 | DXCM | $1.2M | Sale | 50,000 | $24.00 | Discretionary |